I've been considering the recent reforms to the FDA's accelerated approval pathway and their impact on access to treatments. What should be the main focus to ensure these changes benefit patients and healthcare systems effectively? Share your insights by voting below!

What should be the main focus to improve the accelerated approval pathway?